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Abstract 
Maladaptive cardiac remodeling is an important step in the progression of heart failure and 
is characterized by changes in cardiac chamber size, structure, and performance induced by a 
constellation of cell- and tissue-level factors. While great strides have been made in identifying 
membrane receptors, signaling molecules, and transcription factors involved in the remodeling 
process, fundamental questions remain about the molecular pathways linking extracellular stress 
cues to cellular reprogramming underlying progression of disease. Signal Transducer and 
Activator of Transcription 3 (STAT3) is a multifunctional transcription factor which regulates 
expression of gene programs important for inflammation, cell survival, and hypertrophy. While 
STAT3 signaling modulates cardiomyocyte function in response to ischemia and biomechanical 
stress, the molecular pathways that coordinate STAT3 activity is unclear. We hypothesized that 
βIV-spectrin, an actin associated cytoskeletal protein, coordinates a macromolecular complex with 
CaMKII and STAT3 to promote phosphorylation/activation of STAT3 at the cardiomyocyte 
submembrane. We believe that dysfunction of βIV-spectrin will induce cardiac malfunction 
downstream of STAT3. To understand the interaction between STAT3 and βIV-spectrin, novel 
mouse models expressing truncated βIV-spectrin protein lacking the validated CaMKII binding 
domain (qv3J), a cardiac-selective knockout (cKO) of βIV-spectrin, and wildtype littermates were 
used. Cardiac function was assessed by echocardiography at baseline and post Transverse Aortic 
Constriction (TAC). Levels of total and phosphorylated STAT3 and CaMKII were assessed in 
whole heart lysates by western blot, pull-down, and co-immunoprecipitation assays to measure 
relevant protein concentrations and interactions. Permeabilized cardiomyocytes were 
immunostained for βIV-spectrin, CaMKII, and STAT3 and protein localization was assessed by 
confocal microscopy to study the activation and localization of STAT3. βIV-spectrin cKO mice 
showed decreased heart function while qv3J  mice displayed normal cardiac function at baseline 
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and post TAC, compared to wildtype. Mice lacking βIV-spectrin/CaMKII/STAT3 interaction 
demonstrated abnormal STAT3 regulation and response to biomechanical stress. This study 
indicates the presence of a novel complex between βIV-spectrin and STAT3, thereby regulating the 
localization of STAT3 in cardiomyocytes. Future studies will address the specific role of STAT3 
in pathology associated with spectrin-deficiency. 
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Introduction 
Normal cardiac function depends on the ability of the heart to respond to various 
environmental stimuli (i.e. biomechanical/chemical stress, changes in pH, temperature, etc.). At 
the cellular level there are evolved pathways which facilitate the transduction of extracellular 
stimuli into electrical and/or chemical signals important for regulating physiological processes 
such as growth, proliferation, apoptosis, and electrical impulse generation and transmission for 
excitation and contraction. Central to these critical regulatory pathways are local signaling 
domains which exert a tight spatial and temporal control over the post-translational modification 
(i.e. phosphorylation, oxidation, glycosylation) [1]. 
Heart failure (HF) remains a major source of morbidity and mortality in the U.S. that is 
responsible for over 400,000 deaths each year and is affecting an estimated 5.7 million Americans 
with growing prevalence [2]. Maladaptive cardiac remodeling is an important step in the 
progression of HF and is characterized by changes in cardiac chamber size, structure, and 
performance induced by a constellation of cell- and tissue-level factors including hypertrophic 
growth, inflammation, fibrosis, and genetic reprogramming [3]. Although numerous membrane 
receptors, signaling molecules, and transcription factors involved in the remodeling process have 
been identified, specific molecular pathways linking extracellular stress cues to cellular 
reprogramming underlying progression of disease remain unclear. 
βIV-spectrin, an actin-associated cytoskeletal protein, helps maintain the structural integrity 
of cells and organizes local signaling domains for the regulation of ion channels and cell membrane 
excitability  in cardiomyocytes [4]. Specifically, βIV-spectrin targets the multifunctional 
Ca2+/calmodulin-dependent protein kinase II (CaMKII) to ion channel substrates at the 
cardiomyocyte intercalated disc, a specialized membrane domain important for intercellular 
mechanical and electrical communication [3]. CaMKII is a serine/ threonine kinase that has a broad 
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substrate specificity and wide tissue distribution that phosphorylates a variety of different targets 
[5]. While a variety of membrane channels, receptors, and downstream signaling pathways have 
been implicated in mechanotransduction, the mechanistic link between specific biomechanical 
stimuli and cellular remodeling remains unknown. 
Signal Transducer and Activator of Transcription 3 (STAT3), is a multifunctional, stress-
activated transcription factor that regulates expression of gene programs important for cell growth, 
survival, inflammation, metabolism, and cytoprotection [6]. STAT3 plays a critical role in 
communication among cardiomyocytes, myocardial vasculature, and cardiac fibroblasts as well as 
modulation of cardiac microenvironment and its role in the regulation of cardiac inflammation [7]. 
Recent research efforts have shed light on the importance of STAT3 in proper functioning of heart, 
suggesting that STAT3 may serve as a novel therapeutic target for cardiac disease patients [6]. 
While STAT3 signaling modulates cardiomyocyte function in response to ischemia and 
biomechanical stress, the molecular pathways that coordinate STAT3 activity are unclear.  
Tumor Necrosis Factor-alpha (TNF-α) is a cell signaling protein involved in systemic 
inflammation. Increased levels of TNF-α in circulation are known to cause death of 
cardiomyocytes and eventually lead to heart failure [8]. Previous findings have suggested that 
STAT3 is an upstream regulator of TNF-α and is able to regulate inflammatory responses of 
cardiomyocytes and is an important factor for protection and survival of cardiomyocytes in vivo 
[8]. Finding the optimal balance between STAT3 localization and activation may help develop 
novel therapies to treat heart failure, to protect the heart from unwanted drug-related side effects, 
and to protect it from oxidative and biomechanical stress. 
We hypothesized that βIV-spectrin coordinates a macromolecule complex with CaMKII 
and STAT3 to promote phosphorylation/activation of STAT3 at the cardiomyocyte submembrane. 
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We anticipate that dysfunction of βIV-spectrin will induce cardiac malfunction downstream of 
STAT3 and that the novel complex will regulate maladaptive remodeling and arrhythmias in 
response to chronic stress. 
To test our hypothesis, we used two genetically modified mice namely, qv3J, and cardiac-
selective knockout of βIV-spectrin (βIV-spectrin cKO). Wildtype mice have normal physiology and 
contain the full length of βIV-spectrin along with CaMKII binding domains. βIV-spectrin in the qv3J 
mice lack the CaMKII binding domain (CTD) (Figure 1).  
 
 
 
Figure 1: Protein sequence showing CamKII binding domains on the β
IV
-
spectrin protein. Full length of β
IV
-spectrin is conserved in wildtype mice. 
Qv3J mice lack the CaMKII binding domain. 
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Methodology  
Experimental Mice Models 
Adult mouse models that include novel inducible cardiac-selective knockout of βIV-
spectrin (βIV-spectrin cKO), truncated βIV-spectrin protein lacking the validated CaMKII binding 
domain (qv3J), and wildtype (control) were used in this study. The βIV-spectrin cKO mouse model 
was generated from a gene knockout targeting strategy. Specifically, a Cre/Lox system was used 
to remove exons 29 and 30 to generate the βIV-spectrin cKO mouse model (Figure 2). Qv3J mice 
were acquired from Jackson Labs [9].   
 
 
 
 
 
 
 
Figure 2: Schematic showing a Cre/Lox gene knockout targeting strategy used to 
generate the cardiac-specific β
IV
-spectrin knockout mouse model.  
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Echocardiography 
Cardiac function was assessed in-vivo by echocardiography at baseline and post Transverse 
Aortic Constriction (TAC) [10]. Echocardiography uses high frequency sound waves and pulse echo 
effect to generate live images of the heart. In this experiment, mice were anesthetized while an 
ultrasound transducer was placed on their chest. This technique was conducted in 8-week old male 
wildtype littermates, βIV-spectrin cKO, and qv3J to measure the ejection fraction, left ventricular 
chamber diameter, and diastolic left ventricular wall thickness. TAC was performed to evaluate 
the response to chronic adrenergic stress (pressure overload) (Figure 3). Specifically, the mice 
were anesthetized, intubated, and placed on a respirator. The aorta was exposed and then suture 
was tightened around the aorta distal to the brachiocephalic artery.  
 
 
Figure 3: Schematic showing the Transverse Aortic Constriction (TAC) band on the 
heart to induce pressure overload conditions 
[11]
. Suture was tightened around the 
aorta distal to the brachiocephalic artery  
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Western Blotting/Pull-Down/Co-Immunoprecipitation Assays 
Western blotting experiments along with pull-down and co-immunoprecipitation (Co-IP) 
assays were conducted on whole heart lysates to measure relevant protein concentration and 
interaction/association of total and phosphorylated STAT3 and CaMKII with βIV-spectrin. In 
western blot experiments, whole heart lysates, following quantitation by BCA assay, were loaded 
into 4-15% precast gels and transferred to nitrocellulose membranes. The membranes were 
blocked for >1 hour at room temperature in 5% milk and incubated in primary antibody overnight 
at 4oC. Primary antibodies included βIV spectrin (1:1000), ankyrin-G (1:1,000), Nav1.5 (1:500), 
CaMKII (1:500), TREK-1 (1:1000), STAT3 (1:1000), and GAPDH (1:5000). Secondary 
antibodies used were donkey anti-mouse-HRP and donkey-anti rabbit-HRP. Densitometric 
analysis was performed using Image Lab software to determine the presence of target proteins in 
the heart lysate.  
Pull-down assays consisted of glutathione beads bound to a glutathione-s-transferase 
(GST) enzymes [9]. This technique allowed the GST enzymes to be bound to βIV-spectrin proteins 
in heart tissue in which multiple proteins bound to the βIV-spectrin could be investigated. 
Specifically, it allowed the separation of STAT3 bound to βIV-spectrin and in turn probe whether 
these proteins interacted with each other to measure the level of interaction between the two using 
antibodies. After the glutathione beads with GST were added to the heart lysates, the samples were 
loaded into 4-15% precast gels and imaged to determine the level of interaction between βIV-
spectrin and STAT3. 
Co-IP assays used target, protein-specific coupled Resin antibodies to determine the 
association of STAT3 with βIV-spectrin in heart cell lysates of wildtype mice. A similar procedure 
to the pull down assay experiment was utilized to analyze the level of association of STAT3 with 
βIV-spectrin. 
 7 
 
Immunofluorescence  
Cardiomyocytes were isolated from wildtype, βIV-spectrin cKO, and qv3J hearts. Isolated 
cells were fixed and permeabilized in 100% ethanol at -20oC. Cells were blocked in 3% bovine 
serum albumin and 1% fetal goat serum in PBS. Cells were stained with primary antibody 
overnight in blocking solution. Cells were stained with secondary antibodies in blocking solution 
for >1 hour at room temperature. Secondary antibodies included Alexaconjugated donkey anti-
mouse 488, 568 and donkey anti-rabbit 488, 568. Cells were imaged on a LSM 780 confocal 
microscope to study the localization of the STAT3 protein. Cardiomyocytes were imaged using 
identical confocal settings between genotypes. At least 20 cardiomyocytes were examined for each 
staining protocol. 
Enzyme-linked Immunosorbent Assay (ELISA) 
To measure inflammatory responses in the heart, adult ventricular cardiomyocytes were 
treated with an endotoxin, lipopolysaccharide (LPS), at concentrations of 50, 100, and 200 µl and 
cultured for 12 hours. A sandwich enzyme-linked immunosorbent assay (ELISA) experiment was 
used on the cardiomyocyte culture supernatant to quantitatively determine the amount of TNF-α 
secreted. Specifically, 100 µL of the cardiomyocyte cell culture supernatant was added to the pre-
coated antibody wells, followed by an incubation period of two hours. The sample wells were 
aspirated, washed, added with Mouse TNF-α Conjugate, and set for an additional two hour 
incubation. Substrate solution followed with an acidic stop solution was added to stop the reaction 
of the fluorescence. The optical density was immediately determined at wavelengths 450 nm and 
540nm. Based on the standard curve generated, the concentration of the TNF-α secreted from 
wildtype and qv3J cardiomyocytes was determined. 
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Statistical Analysis 
Statistical analysis was performed using the Sigma Plot software. All data is presented in 
the mean ± standard deviation. Statistical significance was assessed using Student’s t-test for a 
pair-wise comparison. ANOVA was used for multiple comparisons. P < 0.05 was considered as 
significant. 
Results 
Echocardiography experiments at baseline revealed a reduction in cardiac function and 
remodeling in cardiac-specific βIV-spectrin cKO (Figures 4 and 5). Ejection fraction was reduced 
in the βIV-spectrin cKO compared to the wildtype mice (P=0.03). Interestingly, there was an 
increase in the cardiac function in the qv3J mice compared to wildtype (P=0.003) or βIV-spectrin 
cKO mice (P=0.01, Figure 5). The anterior and posterior cardiac wall thicknesses were measured 
during diastole. The hearts of βIV-spectrin cKO mice displayed thinner ventricular walls of both 
the anterior and posterior cardiac chambers compared to those of wildtype or qv3J mice (P=0.03 
and 0.04, respectively, Figure 6). In contrast, wall thickening occurred in both the anterior and 
posterior cardiac chambers of the qv3J mice compared to wildtype littermates. The anterior and 
posterior left ventricular walls were also thicker in the qv3J mice compared to βIV-spectrin cKO 
(P=0.04 and 0.02, respectively, Figure 6). The left ventricle of βIV-spectrin cKO mice displayed 
significant dilation at baseline during both the systolic and diastolic phases compared to those of 
wildtype mice (P=0.02 and 0.03, respectively, Figure 7). In contrast, ventricular chamber during 
systolic and diastolic phase were smaller in the qv3J mice indicating a mild hypertrophic response 
in these animals at baseline (P=0.01 and 0.04, respectively, Figure 7).  
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Figure 4: Representative echocardiograms from wildtype, qv
3J
, and β
IV
-spectrin cKO mice 
at baseline. 
Figure 5: At baseline, 8-week old β
IV
-spectrin cKO and qv
3J
 mice show increased and 
decreased ejection fraction, respectively compared to wildtype (control). 
*
P <0.05 in β
IV
-
spectrin cKO and qv
3J
 vs. wildtype, N=5. 
#
P <0.05 in qv
3J
 vs. β
IV
-spectrin cKO, N=5. 
 10 
 
 
 
 
 
Figure 6: Echocardiography at baseline reveals that the anterior and posterior left ventricular 
wall thickness during diastole is thinner in β
IV
-spectrin cKO and thicker in qv
3J
 at baseline 
compared to wildtype littermates (control). 
*
P <0.05 in β
IV
-spectrin cKO and qv
3J
 vs. wildtype, 
N=5. 
#
P <0.05 in qv
3J
 vs. β
IV
-spectrin cKO, N=5. 
Figure 7: Echocardiography at baseline shows an increased LV chamber diameter in β
IV
-
spectrin cKO and decreased LV chamber dimeter in qv
3J
 compared to wildtype littermates 
(control). 
*
P <0.05 in β
IV
-spectrin cKO and qv
3J
 vs. wildtype, N=5. 
#
P <0.05 in qv
3J
 vs. β
IV
-
spectrin cKO, N=5. 
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           Following baseline characterization of heart function in βIV-spectrin cKO, qv3J, and 
wildtype animals, we performed TAC (6 weeks) to evaluate their response to chronic adrenergic 
stress (pressure overload). These experiments revealed a more pronounced maladaptive cardiac 
remodeling βIV-spectrin cKO compared to wildtype or qv3J (Figure 8). There was significant 
decrease in the ejection fraction following 6 weeks of TAC in both wildtype and βIV-spectrin cKO 
mice, with a more severe reduction in βIV-spectrin cKO mice (P=0.002 and 0.003, respectively, 
Figure 9). Histological stains of βIV-spectrin cKO TAC hearts displayed severe remodeling and 
fibrosis following the 6 weeks of TAC compared with wildtype mice and sham controls (Figure 
10). In contrast qv3J animals were resistant to maladaptive remodeling in response to TAC, 
showing a slight increase in ejection fraction following 6 weeks of TAC (Figures 8 and 9). 
 
 
 
 
 
 
 
Figure 8: Representative echocardiograms from wildtype, qv
3J
, and β
IV
-spectrin cKO mice 
after undergoing TAC. 
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Figure 9: Echocardiography shows significant decrease in the ejection fraction in wildtype 
and β
IV
-spectrin cKO mice, but not in the qv
3J
 model after undergoing TAC.
 *
P <0.05 vs Sham, 
N=5.  
Figure 10: Histological sections of TAC β
IV
-spectrin cKO mice show severe 
remodeling and fibrosis compared with wildtype TAC and Sham controls. 
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To determine the mechanism for observed functional differences, preliminary data on the 
DNA microarray of the qv3J TAC hearts was examined (Figure 11). This technique allowed our 
group to measure the expression levels of variety of genes in the TAC hearts. We identified a 
cluster of STAT3 related genes (Figure 11B) and selective transcripts (Nppa, Nppb and Tnfrsf) 
were validated by quantitative RT-PCR (Figure 11C). Natriuretic peptide A (Nppa), natriuretic 
peptide B (Nppb), and tumor necrosis factor receptor superfamily (Tnfsrf) are peptides and 
receptors that are widely used markers for the hypertrophic response in cells or for the development 
of hypertrophy and heart failure related disease in animal models [12]. 
 
 
 
 
 
Figure 11: (A) Heat map depicting gene expression profile between WT and qv
3J
 TAC hearts 
analyzed by microarray (N=3 in triplicate /genotype). (B) A cluster of STAT3-related genes 
met the criteria of having a positive or negative fold change difference ≥ 1.5 vs. WT and P<0.05 
assessed by ANOVA.  (C) Select transcripts (Nppa, Nppb and Tnfrsf) were validated by 
quantitative RT-PCR (N=3, *P<0.05).  
  
 14 
 
To test whether spectrin influences heart function via STAT3 signaling, we first analyzed 
STAT3 levels and localization in βIV-spectrin knock-out mice. Western blot experiments 
demonstrated normal levels of expression of proteins Nav 1.5, TREK-1, GAPDH whereas, Ank-G 
was downregulated in the βIV-spectrin cKO compared to wildtype. Interestingly, the levels of total 
and phosphorylated STAT3 and CaMKII were not altered in the βIV-spectrin cKO mice (Figure 
12). Although STAT3 levels were not altered by spectrin deficiency, immunostaining and confocal 
microscopy showed a loss of normal localization of STAT3 in cardiac-specific βIV-spectrin cKO. 
The wildtype cardiomyocytes displayed a prominent distribution of STAT3 at the intercalated 
discs (marked by N-cadherin) whereas no significant levels of STAT3 were observed at the 
intercalated discs of cardiomyocytes isolated from βIV-spectrin cKO (Figures 13). These data 
suggest that loss of spectrin promotes abnormal subcellular distribution of STAT3.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12: Western blot experiments on whole heart lysate 
showing levels of total and phosphorylated STAT3 and CaMKII 
protein concentrations in wildtype and β
IV
-spectrin cKO mice.    
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To determine the nature of the association between spectrin and STAT3 in heart, we 
performed pull-down and co-immunoprecipitation experiments.  Glutathione S-Transferase (GST) 
protein bound to βIV-spectrin from the pull-down assay suggested the interaction between the GST-
βIV-spectrin fusion protein (βIV-WT) with STAT3 from detergent-soluble mouse heart lysates 
(Figure 14A).  Co-IP experiments showed the association of STAT3 with β
IV
-spectrin in detergent-
soluble lysates from wildtype heart (Figure 14B). 
 
 
 
 
 
Figure 13: Confocal images of wildtype and β
IV
-spectrin cKO cardiomyocytes 
show the localization of proteins through immune-staining and fluorescent 
labeling. Abnormal cellular location of STAT3 is observed in the β
IV
-spectrin 
cKO. Scale bar = 10µm. 
 16 
 
 
Finally, to determine the cellular mechanism for protection from chronic adrenergic stress 
in the qv3J animals, we performed Enzyme-linked Immunosorbent Assay (ELISA) experiments. 
These experiments revealed a suppressed inflammatory reponse in qv3J cardiomyocytes compared 
to the wildtype. After culturing the cardiomyocytes with LPS for 12 hours, there was less TNF-α  
secreted from the qv3J cardiomyocytes compared to wildtype (Figure 15). Future experiments will 
investigate TNF-α seretion in βIV-spectrin cKO cardiomyocyte culture supernatant. 
 
 
 
 
 
 
 
Figure 14: (A) βIV-spectrin directly interacts with STAT3 in   GST- protein pull-
down assays from mouse heart lysate. (B) Co-immunoprecipitation experiments 
showing association of STAT3 with βIV-spectrin in detergent-soluble heart lysates 
from wildtype. 
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Conclusion 
This study indicates an important role for βIV-spectrin in STAT3 localization and regulation 
in cardiomyocytes. βIV-spectrin cKO mice showed decreased heart function with cardiac 
remodeling while qv3J  mice displayed normal cardiac function at baseline and post TAC compared 
to wildtype. Our biochemistry data revealed a novel association between βIV-spectrin and STAT3 
in cardiomyocytes that is essential for normal STAT3 subcellular localization at baseline and 
regulation in response to chronic stress.  Based on this study, we propose a novel complex between 
βIV-spectrin and STAT3 in heart (Figure 16). This βIV-spectrin-based complex organizes a local 
signaling domain with CaMKII and STAT3 to facilitate the sensing and transduction of 
biomechanical stress in cardiomyocytes. Apart from localization, experimental evidence suggests 
that βIV-spectrin also regulates STAT3 activation through CaMKII dependent phosphorylation and 
Figure 15: Adult ventricular wildtype and qv
3J
 cardiomyocytes were 
treated for 12 hours with LPS (50, 100, and 200 µg/ml). Levels of secreted 
TNF-α were assessed by ELISA as a measure of inflammatory response. 
*
P<0.05 vs. wildtype, N= 3. 
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thereby regulate downstream changes in gene expression in response to stress. βIV-spectrin may 
also be a novel player that regulates cardiac inflammation by regulating the localization and 
phosphorylation of  STAT3. This study indicates that the role of βIV-spectrin is not just as an 
important structural component of cardiomyocytes, but also as an important mediator of 
intracellular signaling. Future studies will address the specific role of STAT3 in pathology 
associated with spectrin-deficiency. The specific binding domains responsible for βIV-spectrin-
STAT3 interaction will be investigated. Furthermore, in-vitro phosphorylation on STAT3 and 
CaMKII as well as cardiac rhythmicity will be studied. By doing so, we expect this novel complex 
to serve as a potential therapeutic target for cardiovascular disease patients. 
Figure 16: β
IV
-spectrin may organize a local signaling domain with Ca
2+
/calmodulin 
dependent kinase II (CaMKII) and the transcription factor STAT3 to facilitate STAT 
signaling in response to stress-induced receptor activation. 
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